Philip Morris nabs over 20% of Vectura's shares; Oncopeptides drug may be headed for adcomm, CEO says
About a week after Vectura’s board of directors said they would unanimously back a Philip Morris takeover, the tobacco giant now has control of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
